Autoregulation of hepatic macrophage activation in sepsis

M A West1, R Manthei, M P Bubrick

  • 1Hennepin County Medical Center, Division of Surgical Infectious Disease, Minneapolis, Minnesota 55415.

The Journal of Trauma
|April 1, 1993
PubMed

Insights

Sepsis alters macrophage regulation. Mediators like tumor necrosis factor (TNF) and prostaglandin E2 (PGE2) from activated macrophages can "autoregulate" their own activation state, impacting sepsis progression.

Area of Science:

  • Immunology
  • Cell Biology
  • Pathophysiology

Background:

  • Macrophages play a critical role in sepsis by releasing mediators like TNF and PGE2.
  • Dysregulated macrophage activation is implicated in the complex pathophysiology of sepsis.

Purpose of the Study:

  • To investigate alterations in macrophage regulation during sepsis.
  • To examine the "autoregulatory" role of mediators released by lipopolysaccharide (LPS)-stimulated macrophages on their own activation state.
  • To understand how hepatic macrophages (hMøs) regulate hepatocyte protein synthesis in the context of sepsis.

Main Methods:

  • In vitro pretreatment of hepatic macrophages (hMøs) with TNF alpha, PGE2, subactivating LPS concentrations, or LPS plus indomethacin.
  • Co-culture experiments to assess LPS dose-response relationships for inhibition of hepatocyte protein synthesis.
  • Evaluation of changes in hMø responsiveness following pre-exposure to various stimuli.

Main Results:

  • Pre-exposure to LPS caused a dose-dependent decrease in subsequent LPS-triggered hMø activation.
  • Pretreatment with LPS and indomethacin partially restored hMø responsiveness.
  • Pre-exposure to PGE2 significantly reduced LPS responsiveness, suggesting a PGE2-mediated autoregulatory effect.
  • TNF alpha pretreatment lowered the LPS concentration required for maximal hMø activation.

Conclusions:

  • Macrophage activation state is modulated by both macrophage-derived mediators and prior LPS exposure.
  • These findings support an "autoregulatory" mechanism involving mediators from LPS-stimulated macrophages in the context of sepsis.
  • Understanding these autoregulatory pathways is crucial for developing targeted sepsis therapies.

Related Concept Videos

Autoregulation of Blood Flow01:17

Autoregulation of Blood Flow

Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...